Håkansson, K. E. J. http://orcid.org/0000-0001-5804-0740
Rasmussen, Line J. H.
Godtfredsen, Nina S.
Tupper, Oliver D.
Eugen-Olsen, Jesper
Kallemose, Thomas
Andersen, Ove
Ulrik, Charlotte Suppli
Article History
Received: 18 September 2019
Accepted: 7 November 2019
First Online: 15 November 2019
Ethics approval and consent to participate
: The study was approved by the Danish Health and Medicines Authority (ref. 3–3013-1061/2) and the Danish Data Protection Agency (ref. HVH-2014-018, 02767).
: Not applicable
: KH, NSG, TK, ODT, and CSU have nothing to declare. LJHR has received funding for travel from ViroGates A/S, Denmark, the company that produces the suPARnostic assays. JE-O and OA are inventors of patents on suPAR and prognosis. The patents are owned by Amager and Hvidovre Hospital, Denmark, and licensed to ViroGates A/S. JE-O is co-founder, shareholder, and CSO of ViroGates A/S.